Gene · 6895
Papers1,452
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,452
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated analysis of MYH6, MYH7, and MYH7B expression and their associated microRNAs in human end-stage heart failure. | Front Cardiovasc Med | 2026 | 42630156 | PubTator, text mining | PubMed |
| Steroid-Resistant Idiopathic Nephrotic Syndrome Reveals a Distinct Maladaptive Molecular State. | Kidney Int Rep | 2026 | 42375703 | PubTator, text mining | PubMed |
Revealing the function and mechanism of piRNA-related genes in bladder cancer through single-cell sequencing and methylation analyses and construction of prognostic features based on consensus clustering. | Curr Urol | 2026 | 41668898 | PubTator, text mining | PubMed |
| Staufen dsRNA-binding domain as modules to design bifunctional antibodies for siRNA delivery. | Nucleic Acids Res | 2026 | 41569158 | PubTator, text mining | PubMed |
| The Potential of Noncoding RNAs-siRNAs in Cancer Research and Therapy: Challenges and Solutions. | Exp Suppl | 2026 | 41479113 | PubTator, text mining | PubMed |
| Disrupted miRNA Biogenesis Machinery Reveals Common Molecular Pathways and Diagnostic Potential in MDS and AML. | Biomedicines | 2025 | 41463093 | PubTator, text mining | PubMed |
| A 3,4-diamino-substituted coumarin derivative as a TRBP inhibitor suppresses tumor growth in breast cancer by inducing cellular senescence. | Am J Cancer Res | 2025 | 41244116 | PubTator, text mining | PubMed |
| Targeting RNA-binding proteins with small molecules: perspectives and challenges. | Front Chem | 2025 | 41112581 | PubTator, text mining | PubMed |
| Emerging biomarkers for early cancer detection and diagnosis: challenges, innovations, and clinical perspectives. | Eur J Med Res | 2025 | 40826140 | PubTator, text mining | PubMed |
| TRBP modulates RLR signaling by inhibiting PKR-mediated antiviral stress granule formation. | Sci Rep | 2025 | 40593223 | PubTator, text mining | PubMed |
| RNA Through Time: From the Origin of Life to Therapeutic Frontiers in Transcriptomics and Epitranscriptional Medicine. | Int J Mol Sci | 2025 | 40507776 | PubTator, text mining | PubMed |
| Structural optimization and pharmacological evaluation of diphenyl amine esters as anti-hepatocellular carcinoma agents by targeting TAR RNA-binding protein 2. | Eur J Med Chem | 2025 | 40279767 | PubTator, text mining | PubMed |
| Correction to Supporting Information for Melo et al., Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. | Proc Natl Acad Sci U S A | 2025 | 39951492 | PubTator, text mining | PubMed |
| Single-molecule m6A detection empowered by endogenous labeling unveils complexities across RNA isoforms. | Mol Cell | 2025 | 39922195 | PubTator, text mining | PubMed |
| Role of pH in Modulating RNA-Protein Interactions in TRBP2-dsRBD2: An Interplay between Conformational Dynamics and Electrostatic Interactions. | J Phys Chem B | 2024 | 39722586 | PubTator, text mining | PubMed |
| TRBP2, a Major Component of the RNAi Machinery, Is Subjected to Cell Cycle-Dependent Regulation in Human Cancer Cells of Diverse Tissue Origin. | Cancers (Basel) | 2024 | 39518139 | PubTator, text mining | PubMed |
| Ythdf2 facilitates precursor miR-378/miR-378-5p maturation to support myogenic differentiation. | Cell Mol Life Sci | 2024 | 39503763 | PubTator, text mining | PubMed |
| New insights into the function and therapeutic potential of RNA-binding protein TRBP in viral infection, chronic metabolic diseases, brain disorders and cancer. | Life Sci | 2024 | 39447729 | PubTator, text mining | PubMed |
| AGO2 protein: a key enzyme in the miRNA pathway as a novel biomarker in adrenocortical carcinoma. | Endocr Relat Cancer | 2024 | 39404265 | PubTator, text mining | PubMed |
| A healthy heart for all: boosting cardiac surgery access in low-income countries. | Int J Surg | 2024 | 38935826 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6895/papers